Among 7697 consecutive patients with multivessel coronary artery disease, MI rates after PCI were 18.7%, 3.2%, and 5.5% with the second universal definition of MI (UDMI), third UDMI, and the Society ...
Nearly 3 years ago, the CHAMPION trials found that the novel antiplatelet cangrelor failed to reduce ischemic events compared with clopidogrel in the context of percutaneous coronary intervention (PCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results